Literature DB >> 18630807

Adult obesity at the beginning of the 21st century: epidemiology, pathophysiology and health risk.

E Ginter1, V Simko.   

Abstract

Obesity is defined as increased body weight caused by excessive accumulation of fat. Due to a very long period of undernutrition in human history, the contemporary human body regulation mechanisms seem to be biased in favor of preserving fat rather to eliminate it. At the highest risk are populations that suddenly gained wealth. The shift from undernutrition to overnutrition has occurred in a very short time, in many population groups in less than in one generation. The increase of obesity prevalence observed in the 20th century continues until present and it appears this trend will further continue in almost all countries in the world. Contemporary prevalence of adult obesity is very high in USA (33% in both gender), in oil-rich Arabian countries (30% in males, 40 % in females) and in European Union (up to 25% in both gender). The aim of contemporary research is to understand the molecular and neural systems which the body uses to regulate its storage of energy in the form of fat and how these systems can become unbalanced, leading to obesity. In spite of discovery of new hormones (e.g. leptin produced in adipose tissue) and of new mechanisms, the prevention and treatment of obesity remains an open problem. Obesity is associated with an increased risk of numerous comorbidities such as type 2 diabetes, metabolic syndrome, hypertension, cardiovascular diseases and osteoarthritis. In USA the impact of obesity on mortality may have decreased over time, perhaps because of improvements in public health and medical care. New data from USA and China suggest the lowest all-cause mortality in persons with a body mass index, BMI between 23.0 and 27.0 (Fig. 6, Tab. 1, Ref. 29). Full Text (Free, PDF) www.bmj.sk.

Entities:  

Mesh:

Year:  2008        PMID: 18630807

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  6 in total

1.  Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet.

Authors:  Yu-Kun Jennifer Zhang; Kai Connie Wu; Jie Liu; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-24       Impact factor: 4.219

2.  Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding.

Authors:  Charles Sabbagh; Pierre Verhaeghe; Abdennaceur Dhahri; Olivier Brehant; David Fuks; Rachid Badaoui; Jean-Marc Regimbeau
Journal:  Obes Surg       Date:  2009-11-10       Impact factor: 4.129

3.  Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.

Authors:  Soona Shin; Junko Wakabayashi; Melinda S Yates; Nobunao Wakabayashi; Patrick M Dolan; Susan Aja; Karen T Liby; Michael B Sporn; Masayuki Yamamoto; Thomas W Kensler
Journal:  Eur J Pharmacol       Date:  2009-08-19       Impact factor: 4.432

4.  Early nutrition and adult health: Perspectives for international and community nutrition programs and policies.

Authors:  Daniel J Hoffman
Journal:  Nutr Res Pract       Date:  2010-12-31       Impact factor: 1.926

5.  Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity.

Authors:  Sumei Lu; Qingbo Guan; Yuantao Liu; Haibo Wang; Wei Xu; Xia Li; Yuchang Fu; Ling Gao; Jiajun Zhao; Xiangdong Wang
Journal:  Lipids Health Dis       Date:  2012-01-30       Impact factor: 3.876

6.  Obesity and overweight prevalences in rural and urban populations in East Spain and its association with undiagnosed hypertension and Diabetes Mellitus: a cross-sectional population-based survey.

Authors:  Antonio Hernández-Mijares; Eva Solá-Izquierdo; Francisco Ballester-Mechó; María Teresa Marí-Herrero; Juan Vicente Gilabert-Molés; Natalia Gimeno-Clemente; María Morales-Suárez-Varela
Journal:  BMC Res Notes       Date:  2009-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.